Financial conflicts of interest (FCOI) may unduly influence physician decision-making. For this reason, the Institute of Medicine recommends that guideline development teams be composed of at most 50% authors who have financial relationships to disclose, and recommends abstaining from financial conflicts for a period of 1 year following guideline publication.1 Several studies have evaluated the extent of FCOI between industry and authors of clinical practice guidelines (CPGs) in dermatology,2 oncology,3 and otolaryngology4; however, such an analysis has not been performed in gastroenterology. Our objectives were to evaluate industry payments received by, and FCOI disclosure practices of, authors of 15 gastroenterology clinical practice guidelines.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Combs TR, Scott J, Jorski A, Heavener T, Vassar M. Evaluation of Industry Relationships Among Authors of Clinical Practice Guidelines in Gastroenterology. JAMA Intern Med. 2018;178(12):1711–1712. doi:10.1001/jamainternmed.2018.4730
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: